Call Options

30 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$39.66 - $51.75 $20.3 Million - $26.4 Million
510,920 Added 348.92%
657,347 $34 Million
Q2 2024

Aug 13, 2024

SELL
$40.25 - $52.99 $6.24 Million - $8.21 Million
-155,000 Reduced 51.42%
146,427 $6.08 Million
Q1 2024

May 13, 2024

SELL
$47.98 - $54.4 $70.6 Million - $80.1 Million
-1,471,673 Reduced 83.0%
301,427 $16.3 Million
Q4 2023

Feb 09, 2024

BUY
$48.48 - $57.85 $8.49 Million - $10.1 Million
175,200 Added 10.96%
1,773,100 $91 Million
Q3 2023

Nov 09, 2023

BUY
$57.89 - $64.73 $32.2 Million - $36 Million
556,500 Added 53.44%
1,597,900 $92.7 Million
Q2 2023

Aug 11, 2023

SELL
$63.71 - $70.74 $13.5 Million - $15 Million
-212,300 Reduced 16.93%
1,041,400 $66.6 Million
Q1 2023

May 12, 2023

SELL
$65.71 - $74.53 $1.01 Million - $1.14 Million
-15,300 Reduced 1.21%
1,253,700 $86.9 Million
Q4 2022

Feb 08, 2023

BUY
$68.48 - $81.09 $49.4 Million - $58.5 Million
721,500 Added 131.78%
1,269,000 $91.3 Million
Q3 2022

Nov 10, 2022

BUY
$0.13 - $76.84 $7,046 - $4.16 Million
54,200 Added 10.99%
547,500 $38.9 Million
Q2 2022

Aug 10, 2022

BUY
$72.62 - $79.98 $5.81 Million - $6.4 Million
80,000 Added 19.36%
493,300 $38 Million
Q1 2022

May 16, 2022

BUY
$61.48 - $73.72 $9.12 Million - $10.9 Million
148,300 Added 55.96%
413,300 $30.2 Million
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $11.4 Million - $13.2 Million
211,834 Added 398.44%
265,000 $16.5 Million
Q2 2021

Aug 13, 2021

SELL
$61.91 - $67.42 $63.3 Million - $68.9 Million
-1,022,600 Reduced 95.06%
53,166 $3.55 Million
Q1 2021

May 12, 2021

BUY
$59.34 - $66.74 $32.7 Million - $36.8 Million
550,966 Added 104.99%
1,075,766 $67.9 Million
Q4 2020

Feb 11, 2021

BUY
$57.74 - $65.43 $5.83 Million - $6.6 Million
100,900 Added 23.8%
524,800 $32.6 Million
Q3 2020

Nov 12, 2020

SELL
$57.43 - $63.64 $5.96 Million - $6.61 Million
-103,800 Reduced 19.67%
423,900 $25.6 Million
Q2 2020

Jul 31, 2020

SELL
$54.82 - $64.09 $19 Million - $22.2 Million
-347,000 Reduced 39.67%
527,700 $31 Million
Q1 2020

May 01, 2020

BUY
$46.4 - $67.43 $13.6 Million - $19.7 Million
292,200 Added 50.16%
874,700 $48.8 Million
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $4.38 Million - $5.72 Million
89,100 Added 18.06%
582,500 $37.4 Million
Q3 2019

Nov 14, 2019

SELL
$42.77 - $50.71 $2.72 Million - $3.23 Million
-63,700 Reduced 11.43%
493,400 $25 Million
Q2 2019

Aug 14, 2019

SELL
$44.62 - $49.34 $3.48 Million - $3.84 Million
-77,900 Reduced 12.27%
557,100 $25.3 Million
Q1 2019

May 14, 2019

SELL
$45.12 - $53.8 $6.65 Million - $7.92 Million
-147,300 Reduced 18.83%
635,000 $30.3 Million
Q4 2018

Feb 14, 2019

BUY
$48.76 - $63.23 $36.3 Million - $47.1 Million
744,200 Added 1953.28%
782,300 $40.7 Million
Q3 2018

Nov 14, 2018

BUY
$55.19 - $62.25 $88,304 - $99,600
1,600 Added 4.38%
38,100 $2.37 Million
Q2 2018

Aug 14, 2018

SELL
$50.53 - $62.98 $76.9 Million - $95.8 Million
-1,521,800 Reduced 97.66%
36,500 $2.02 Million
Q1 2018

May 15, 2018

BUY
$59.92 - $68.98 $80 Million - $92.1 Million
1,335,400 Added 599.1%
1,558,300 $98.6 Million
Q4 2017

Feb 14, 2018

SELL
$59.94 - $65.35 $1.23 Million - $1.34 Million
-20,500 Reduced 8.42%
222,900 $13.7 Million
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $13.3 Million - $15.4 Million
241,630 Added 13651.41%
243,400 $15.5 Million
Q2 2017

Aug 14, 2017

SELL
N/A
-4,013,080 Reduced 99.96%
1,770 $99,000
Q1 2017

Nov 14, 2017

BUY
N/A
4,014,850
4,014,850 $218 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.